Skip to main content

University of Maryland School of Medicine Announces Appointment of Chancellor Brit Kirwan, Other Prominent Leaders to its Board

June 29, 2015

William “Brit” E. Kirwan

Retiring Chancellor to Continue His Longtime Support of the School of Medicine; Will Join Other New and Recently-Appointed Board Members Louis F. Angelos, Abba D. Poliakoff, Patricia J. Mitchell, Cynthia Egan and Laura Gamble

University of Maryland School of Medicine (UM SOM) Dean E. Albert Reece, MD, PhD, MBA, and UM SOM Board of Visitors Chairman, Michael E. Cryor today announced the appointment of new board members, including prominent leaders from academia, business and law.

Most notable among those who will serve on the UM SOM Board, is retiring University System of Maryland (USM) Chancellor William “Brit” E. Kirwan, who will join the UM SOM Board, effective July 1, 2015. Dr. Kirwan, who in his 13 years as Chancellor was known for playing an integral role in the School’s growth and success, joins other new UM SOM Board appointees: Louis F. Angelos, JD, an attorney at the Law Offices of Peter G. Angelos, PC, and Ownership Representative of the Baltimore Orioles; and Abba David Poliakoff, Partner and Chairman of Securities Law Practice Group at Gordon Feinblatt, LLC;

Other recent appointees have included: Patricia J. (“P.J.”) Mitchell, a Corporate Director, Executive Consultant and Community Leader, who previously led worldwide sales operations for IBM Global Technology Services Cynthia Egan, currently Director at Envestnet and former President of Retirement Plan Services for T. Rowe Price Group;; and Laura Gamble, President, Maryland Regional, The PNC Financial Services.

“We are extremely fortunate to welcome this most recent group of highly successful leaders, innovators and thinkers to our board,” said Mr. Cryor. “These are all individuals who truly represent the best in their fields of education, financial services, global business, law, and technology. If a board is reflective of the quality of the institution, it is quite clear that the University of Maryland School of Medicine is reaching new and greater heights as one of the leading medical schools and biomedical research institutions in the nation and indeed the world,” he said.

“These newest board appointees represent an extraordinary group of leaders,” said Dean Reece, who is also Vice President for Medical Affairs, University of Maryland, and the John Z. and Akiko K. Bowers Distinguished Professor. “The School and the Board will benefit greatly from the tremendous diversity of backgrounds and perspectives that they will provide. We are particularly grateful that Dr. Kirwan will be continuing his longstanding engagement and support of the School of Medicine,” he added. “We look forward to the thoughtful input and strategic counsel we will receive from him as well as from all of our new and current board members,” he said.

Brit Kirwan: A Continuing Legacy

Dr. Kirwan has had a long and distinguished 50-year career in academia, holding positions of leadership for 37 of those years, including as department chair, vice chancellor for academic affairs, provost, president at two major universities and then chancellor of the 12-campus University System of Maryland. Over the course of his career, he has received numerous honors and awards, including two of the highest honors given in the field of higher education: the TIAA-CREF Theodore M. Hesburgh Award for Leadership Excellence, for leadership and commitment to higher education, and the Carnegie Corporation Leadership Award, for commitment to excellence in undergraduate education and outreach to communities. He has authored many articles on issues in higher education and is recognized worldwide as a tireless advocate for the value and necessity of education. Dr. Kirwan received his bachelor's degree in mathematics from the University of Kentucky and his master's and doctoral degrees in mathematics from Rutgers, The State University of New Jersey.

In a recent interview, Dr. Kirwan talked about the close partnership he has had with the SOM and its leadership, Dean Reece over the past many years, noting that “the School is a true star in the University System that will continue to shine brightly.” He pointed to the construction of HSF III, the new SOM biomedical research building, as well as the MPower Initiative and UM Ventures, as exemplary of the tremendous collaboration between SOM, the University of Maryland, Baltimore (UMB) and its President Jay Perman, and the University System.

““Dr. Kirwan’s wisdom and in-depth knowledge of the SOM, UMB and USM will be invaluable to us as we move the School’s Vision 2020 forward,” Dean Reece said. “Moreover, with the additions of Louis Angelos and Abba Poliakoff along with Cynthia Egan, P.J. Mitchell, and Laura Gamble, we now have a tremendous breadth of expertise and experience in key areas that will help guide the refinement and implementation of our Strategic Plan.”

A Leader in Law and Management

Louis F. Angelos, JD, has established himself as one of the bright new legal minds in Maryland. A 1992 graduate of Johns Hopkins University and a graduate of St. Thomas University Law School, he was admitted to the Bar in 2000. Joining the Law Offices of Peter Angelos, P.C., he represents clients across a range of the firm’s practice areas, which include Mesothelioma, Product and Medical Device Liability, Pharmaceutical Liability, Birth Injury, Medical Malpractice, Class Action Lawsuits, Environmental Litigation and Personal Injury. He is also Owner Representative of the Baltimore Orioles. Louis’s father, Peter Angelos, has been a longtime SOM board member and currently serves the board in an Emeritus capacity.

A Leader in Business Law and Biotechnology

Abba Poliakoff is a senior business and technology lawyer, specializing in corporate & securities, venture capital, and intellectual property law at Gordon Feinblatt, LLC. He is Chair of the firm's Securities Law practice and is counsel to public and private companies, larger corporations as well as emerging businesses. His experience includes raising capital, public offerings, private placements, mergers & acquisitions, and general legal and business consulting, with a special focus on technology and biotech. A graduate of Ner Israel College, Mr. Poliakoff was Chairman of the Maryland/Israel Development Center, a joint venture between the State of Maryland and the Israeli Ministry of Industry and Trade and is a co-founder and Board Member of the Maryland Middle East Chamber of Commerce. He was appointed by then Governor Martin J. O’Malley to the Governor’s International Advisory Council on International Commerce and Trade.

A Global Technology Executive, Board Director and Award-Winning Consultant

Ms. Mitchell is a highly accomplished corporate director and executive consultant recognized for her expertise in strategic planning and executive compensation. She is a sought after speaker at national and international executive conferences and has been recognized for her leadership in developing and executing strategic plans for both commercial and nonprofit organizations, for her expertise in the area of women’s leadership and philanthropy, and for her expertise in both non-profit and corporate executive compensation. Ms. Mitchell retired in 2010 as Vice President of Global Sales Operations for IBM Global Technology Services, where she was responsible for worldwide sales strategy, professional development, incentive planning and sales operations. In this capacity, Ms. Mitchell chaired the Global Sales Operations Council for IBM Global Services. Prior to this position, she had advanced up the ranks at IBM Global Services, starting with sales and marketing positions in the company’s Mid-Atlantic Region.

A Leader in Financial Services

Cynthia Egan is a dynamic business leader who has had a highly successful career as a senior executive in financial services and as an advocate for workplace diversity. Since 2013, she has served on the board of Envestnet, a leading provider of integrated portfolio, practice management and reporting solutions. Previously, she was President, Retirement Plan Services for T. Rowe Price Group, an investment firm, from 2007 to 2012. While at T. Rowe Price Group, she also served as a member of the T. Rowe Price Operational Steering Committee and the T. Rowe Price Trust Company Board, Staff Compensation Committee, Diversity Roundtable and as the founding Chair of the T. Rowe Price Women’s Roundtable. Ms. Egan progressed to President, Fidelity Charitable Gift Fund and head of Fidelity Institutional Service Company in a career starting in 1989 through 2007. Ms. Egan received a BA from Boston College.

An Influential Banker in Maryland

Ms. Laura Gamble has been President - Maryland Regional at PNC Financial Services Group Inc. since April 23, 2012. Ms. Gamble co-founded Skipjack Partners LLC. Ms. Gamble spent 23 years with Bank of America. She served as the President of Bank of America, Maryland. She served as the Chairman of the Board of Economic Alliance of Greater Baltimore, Inc. until November 2009. She served as a Member of Advisory Board at Evergreen Advisors, LLC. Ms. Gamble was recognized as one of the Top 100 Women in Maryland in 2007 and 2004. She has also been named to the Baltimore Power 20 by the Baltimore Business Journal and as one of the Most Influential Marylanders by The Daily Record. She serves on several civic and philanthropic boards of directors including the Economic Alliance of Greater Baltimore, the Baltimore Community Foundation, the Central Maryland Transportation Alliance, and the Sheppard Pratt Health System. She is a Six Sigma Greenbelt and a FINRA Registered Principal with Series 7, 24 and 66 securities licenses. Ms. Gamble received a BS degree from the University of North Carolina at Chapel Hill in Business Administration.

About the University of Maryland School of Medicine Board of Visitors

The School’s Board of Visitors is an advisory board currently comprising 27 total members*, including: Michael E. Cryor, Chair, Board of Visitors, President, The Cryor Group, Baltimore, MD ; Peter G. Angelos, Esq., Emeritus Board Member, President, Law Offices of Peter G. Angelos, PC, Baltimore, MD; Louis F. Angelos, JD, attorney at the Law Offices of Peter G. Angelos, PC, and Ownership Representative of the Baltimore Orioles; Kenneth R. Banks, President, Banks Contracting Company, Baltimore, MD; George M. Boyer, MD (Ex-Officio Member) President, Medical Alumni, Assoc. of the University of MD, Baltimore, MD; Jocelyn Cheryl Bramble, Publisher, The Baltimore Times, Baltimore, MD; Cynthia Egan, Director, Envestnet, Baltimore, MD; Robert C. Embry, Jr.,President, The Abell Foundation, Baltimore, Maryland ; Robert E. Fischell, ScD, President, Fischell BioMedical, LLC, Dayton, MD; Carolyn Frenkil, President, Center City, Inc., Baltimore, MD; Laura Gamble, Regional President of Greater Maryland, PNC Bank, Baltimore, MD; Michael Greenebaum, President, Greenebaum Enterprises, Baltimore, MD; Stewart J. Greenebaum, Founding Partner, Greenebaum Enterprises, Baltimore, MD; Jeffrey L. Hargrave, President, Mahogany, Inc. Baltimore, MD; John R. Kelly, President & Senior Consultant, Kelly Benefit Strategies, Baltimore, MD; William “Brit” Kirwan, PhD, Former Chancellor, University System of Maryland, Adelphi, MD; Harry C. Knipp, MD, FACR, Founding Member, Advanced Radiology PA, Baltimore, MD; Patrick McCuan, President & CEO, MDG Companies, Columbia, MD; Patricia J. Mitchell, Baltimore, MD; Edward Magruder Passano, Jr., President & Chief Executive Officer, One Waverly, LLC Baltimore, MD; Abba D. Poliakoff, Partner and Chairman of Securities Law Practice Group at Gordon Feinblatt, LLC, Baltimore, MD; ; Timothy J. Regan, President & Chief Executive Officer, The Whiting-Turner Contracting Company, Baltimore, MD; Tim Ryan, Publisher, President & CEO, Baltimore Sun Media Group, Baltimore, MD; Melvin Sharoky, MD, Past Chair, Board of Visitors, Member and Former Chairman of the Board of Directors, Insmed, Royal Oak, Maryland; and Richard L. Taylor, MD, FAAN, Founding Member, Taylor Medical Group; Baltimore, MD; .

*includes emeritus and ex-officio members

About the University of Maryland School of Medicine

The University of Maryland School of Medicine, chartered in 1807 as the first public medical school in the United States, continues today as a leader in accelerating innovation and discovery in medicine. The School of Medicine is the founding school of the University of Maryland, and is an integral part of the 11-campus University System of Maryland. Located on the University of Maryland’s Baltimore campus, the School of Medicine works closely with the University of Maryland Medical Center and Medical System to provide a research-intensive, academic and clinically based education. With 43 academic departments, centers and institutes and a faculty of more than 3,000 physicians and research scientists, plus more than $400 million in extramural funding, the School is regarded as one of the leading biomedical research institutions in the U.S.A., with top-tier faculty and programs in vaccine development, cancer, brain science, surgery and transplantation, trauma and emergency medicine, and human genomics, among other centers of excellence. The School is not only concerned with the health of the citizens of Maryland and the U.S.A., but also has a global presence, with research and treatment facilities in more than 35 countries around the world.


Office of Public Affairs
655 West Baltimore Street
Bressler Research Building 14-002
Baltimore, Maryland 21201-1559

Contact Media Relations
(410) 706-5260

Related stories